Analgesic Effects of β-Phenylethylamine and Various Methylated Derivatives in Mice

Neurochemical Research

Volumn 39, Issue 9, 2014, Pages 1675-1680

  Mosnaim, Aron D ^a   Hudzik, Thomas ^b   Wolf, Marion E ^c  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b ABBVIE INC   (United States)

^c International Neuropsychiatry Consultants   (United States)

Author keywords

Amphetamine; Analgesia; Antinociceptive effects; Methylated phenylethylamine derivatives; Stimulant behavior; Phenylethylamine

Indexed keywords

ANALGESIC AGENT; PHENETHYLAMINE; PHENETHYLAMINE DERIVATIVE;

ANIMAL; DOSE RESPONSE; MALE; METHYLATION; MOUSE;

ANALGESICS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; METHYLATION; MICE; PHENETHYLAMINES;

EID: 84939896139     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-014-1354-7     Document Type: Article

References (36)

1. Westfall TC, Westfall DP (2011) Adrenergic agonists and antagonists. In: Brunton LL, Chabner BA, Krollmann BC (eds) Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 12th edn. McGraw Hill, New York, pp 277–333
2. Shulgin A, Shulgin A (1991) Phenethylamines I have known and loved: a chemical love story. Transform Press, Berkeley
3. Berry MD (2004) Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators. J Neurochem 90:257–271
4. Mosnaim AD, Wolf ME (eds) (1978) Non-catecholic phenylethylamines. Part 1: phenylethylamine: biological mechanisms and clinical aspects. Marcel Dekker, USA
5. Mosnaim AD, Wolf ME (eds) (1978) Non-catecholic phenylethylamines. Part 2: phenylethanolamine, tyramines and octopamine. Marcel Dekker, USA
6. www.healthremedies.com (Accessed 2014, Copyrights 2008-2014)
7. Fischer EE, Heller BB, Miro AH (1968) Beta-phenylethylamine in human urine. Arzneimittelforschung 18(11):1486
8. Sabelli HC, Mosnaim AD (1974) Phenylethylamine hypothesis of affective behavior. Amer J Psychiatry 131:695–699
9. Wolf ME, Mosnaim AD (1983) Phenylethylamine in neuropsychiatric disorders. Gen Pharmacol 14(4):385–390
10. Pawar RS, Grundel E, Fardin-Kia AR, Rader JI (2014) Determination of selected biogenic amines in Acacia rigidula plant materials and dietary supplements using LC–MS/MS methods. J Pharmaceutical Biomed Analysis 88:457–466
11. Inwang EE, Mosnaim AD, Sabelli HC (1973) Isolation and characterization of phenylethylamine and phenylethanolamine from human brain. J Neurochem 20:1469–1473
12. Saavedra JM (1974) Enzymatic isotopic assay for and presence of β-phenylethylamine in brain. J Neurochem 22:211–216
13. Karoum F, Nasrallah H, Potkin S, Chuang L, Moyer-Schwing J, Phillips I, Wyatt RJ (1979) Mass fragmentography of phenylethylamine, m- and p-tyramine and related amines in plasma, cerebrospinal fluid, urine, and brain. J Neurochem 33(1):201–212
14. Hansen TR, Greenberg J, Mosnaim AD (1980) Direct effect of phenylethylamine upon isolated vascular smooth muscle of the rat. Europ J Pharmacol 63:95–101
15. 3Hbeta-phenylethylamine binding sites in rat brain. Eur J Pharmacol 83:147–148
16. Fehler M, Broadley KJ, Ford WR (2010) Kidd EJ (2010) Identification of trace-amine-associated receptors (TAAR) in the rat aorta and their role in vasoconstriction by β-phenylethylamine. Naunyn Schmiedebergs Arch Pharmacol 82(4):385–398
17. Boulton AA (1980) Trace amines and mental disorders. Can J Neurol Sci 7:261–263
18. Mosnaim AD, Callaghan OH, Wolf ME (1981) Determination of non-catecholic phenylethylamines and monomethylated derivatives of phenylethylamines. J Chromatogr Biomed Appl 224:481–487
19. Yang HYT, Neff NH (1973) B-Phenylethylamine: a specific substrate for type B monoamineoxidase in brain. J Pharm Exp Therap 187:365–371
20. Durden DA, Davis BA (1993) Determination of regional distribution of phenylethylamine and meta- and para-tyramine in rat brain regions and presence in human and dog plasma by an ultra-sensitive negative chemical ion gas chromatography-mass spectrometric (NCI-GC-MS) method. Neurochem Res 18:995–1002
21. Mosnaim AD, Wolf ME, Zeller EA (1984) Degradation kinetics by MAO of PEA derivatives: a model for the molecular basis of their analgesic and behavioral effects? In: Boulton A, Baker G, Dewhurst W, Sandler M (eds) Neurobiology of trace amines. Humana Press, New Jersey, pp 299–306
22. Chevesich JA, Callaghan OH, Wolf ME, Mosnaim AD (1983) Behavioral effects in mice produced by monosubstituted phenylethylamines. Fed. Proc. Chicago
23. Mosnaim AD, Callaghan OH, Hudzik T, Wolf ME (2013) Rat brain-uptake index for phenylethylamine and various monomethylated derivatives. Neurochem Res 38(4):842–846
24. Matsuoka Y, Masafumi S, Toshihiko S, Yasufumi T, Tsutomu U, Kazuhiko K (1988) Characteristics of antinociception induced by noncatecholic phenylethylamine derivatives: the relation of endogenous norepinephrine to phenylethylamine analog-induced antinociception. Japan J Pharmacol 48:263–272
25. Lindemann L, Hoener MC (2005) A renaissance in trace amines inspired by a novel GPCR family. Trends Pharmacol Sci 26(5):274-81. http://www.ncbi.nlm.nih.gov/pubmed/15860375
26. Berry MD (2007) The potential of trace amines and their receptors for treating neurological and psychiatric diseases. Reviews on Recent Clinical Trials. 2:3–19
27. Bunzow JR, Sonders MS, Arttamangkul S, Harrison LM, Zhang G, Quigley DI, Darland T, Suchland KL, Pasumamula S, Kennedy JL, Olson SB, Magenis RE, Amara SG, Grandy DK (2001) Amphetamine, 3,4methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol Pharmacol 60:1181–1188
28. Borowsky B, Adham N, Jones KA, Raddatz R, Artymyshyn R, Ogozalek KL, Durkin MM, Lakhlani PP, Bonini JA, Pathirana S, Boyle N, Pu X, Kouranova E, Lichtblau H, Ochoa FY, Branchek TA, Gerald C (2001) Trace amines; identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci USA 98(16):8966–8971
29. Maguire JJ, Barriocanal FP, Davenport AP (2002) Are vasoconstrictor responses to tyramine in human blood vessels, in vitro, mediated by the orphan trace amine receptor, TA1. Br J Pharmacol 131:71P
30. Lewin AH (2006) Receptors of mammalian trace amines. AAPS J 8(1), Article 16:E138–E145, 2006
31. www.idmu.co.uk/amphetpain.htm Independent Drug Monitoring Unit, UK (Accessed 2014)
32. www.wada-ama.org World Anti-Doping Agency (Accessed 2014)
33. Drago F, Caccamo G, Continella G, Scapagnini U (1984) Amphetamine-induced analgesia does not involve brain opioids. Eur J Pharmacol 101(3–4):267–269
34. Dalal S, Melzack RJ (1988) Potentiation of opioid analgesia by psychostimulant drugs: a review. Pain Symptom Manag 6(4):245–253
35. Sabelli HC, Vazquez AJ, Mosnaim AD, Madrid-Pedemonte L (1974) 2-Phenylethylamine as a possible mediator for 9-tetrahydrocannabinol-induced stimulation. Nature 248:144–145
36. Yaksh TL, Wallace MS (2011) Opioids, analgesics and pain management. In: Brunton LL, Chabner BA, Krollmann BC (eds) Goodman and Gilman’s the pharmacological basis of therapeutics, 12th edn. McGraw Hill, New York, pp 480–525